Title:
ANTIBODY AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2004/106382
Kind Code:
A1
Abstract:
An antibody reacting specifically with a partial peptide in the N-terminal side or the C-terminal side of NPW that makes it possible to highly sensitively and specifically quantify NPW. Moreover, this antibody is useful as a preventive/remedy and a diagnostic for infertility, renal edema, digestive ulcer, gastric hyperacidity, etc.
Inventors:
MORI MASAAKI (JP)
SHIMOMURA YUKIO (JP)
SHIMOMURA YUKIO (JP)
Application Number:
PCT/JP2004/007667
Publication Date:
December 09, 2004
Filing Date:
May 27, 2004
Export Citation:
Assignee:
TAKEDA PHARMACEUTICAL (JP)
MORI MASAAKI (JP)
SHIMOMURA YUKIO (JP)
MORI MASAAKI (JP)
SHIMOMURA YUKIO (JP)
International Classes:
A61P1/00; A61P1/04; A61P13/12; A61P15/00; C07K16/18; C07K16/26; C12P21/08; (IPC1-7): C07K16/28; A61K39/395; A61P1/00; A61P1/04; A61P13/12; A61P15/00; C12N5/10; C12P21/08; G01N33/53; G01N33/577
Domestic Patent References:
| WO2001098494A1 | 2001-12-27 | |||
| WO2002102847A1 | 2002-12-27 | |||
| WO2003082907A1 | 2003-10-09 |
Other References:
See also references of EP 1627888A4
J. SAMBROOK ET AL.: "Molecular Cloning", 1989, COLD SPRING HARBOR LAB. PRESS
J. SAMBROOK ET AL.: "Molecular Cloning", 1989, COLD SPRING HARBOR LAB. PRESS
Attorney, Agent or Firm:
Takahashi, Shuichi c/o Osaka Plant of Takeda Pharmaceutical Company Limited (17-85 Jusohonmachi 2-chome, Yodogawa-k, Osaka-shi Osaka, JP)
Download PDF:
Previous Patent: HUMAN-ANTI-HUMAN CD3 BINDING MOLECULES
Next Patent: MONOCLONAL ANTIBODIES SPECIFIC FOR BUPRENORPHINE AND METABOLITES THEREOF
Next Patent: MONOCLONAL ANTIBODIES SPECIFIC FOR BUPRENORPHINE AND METABOLITES THEREOF